Excellent point regarding the short squeeze strategy. And MKR certainly knows what they are doing.
However, I think a CRON merger is a long shot and potentially more Ammo for those already calling this a pump and dump, especially if May 9th comes and VRUS isn’t mentioned. Although I would never be so arrogant as to claim certainty, I think their are greater ambitions at work here and this is why:
1. Does Garnock even have a stake in CRON at this point? If so, is it still less than ten percent?
2. Cronos is basically Altria now and Altria may not need help with global distribution - they have a pretty good
size foot print. And certainly not discounting AG, but he’s not Altria.
3. “Cronos group is committed to building disruptive intellectual property” - thecronosgroup.com.
AG and Co. created and operate disruption-labs (disruption-labs.com). Why is this not under CRON already?
4. CRON subsidiary - Ginkgo Bioworks ‘nanoscale presicion’ - ginkgobioworks.com
AG and Co. created and operate reset bioscience (resetbioscience.com) - “nanotechnology delivers greater
bioavailability”. Why is this not under CRON already?
5. Even if CRON had a need, why merge when you can quickly build your own small empire and attract the
the next level Altria size investors/competitors on your controlling VRUS stake instead of your less than 10%
CRON stake (if he is even still holding).
6. I’m sure multiple Wholefoods/Amazon type companies will be looking to drop a few billion to establish their
presence in this market within the year.
On the flip side, maybe VRUS packages it all up and Altria/CRON does have interest. I don’t know if they’re quite ready to fill Kraft’s shoes but who’s to say.
Either way, I’m just glad I’m holding here.
News 
Market Data 
Discover 
AI
